Market Pulse

 
img

The show gets you real-time updates on the stock markets and live reporting on all the latest business and market developments


img

Jan WPI At 2.84% Vs 3.58% MoM

February 15: Inflation Based On Wholesale Prices Eased To A Six-Month Low Of 2.84 Per Cent In January On Cheaper Food Articles Even As Vegetable Prices Continued To Rule High.


img

Mannapuram Fin Q3: PAT Down 14%

February 9: Manappuram Finance Has Reported A 14 Percent Decline In Its Consolidated Net Profit To Rs 173 Crore In The Third Quarter Ended December 31. To Decode The Quarter In Detail, We Spoke To VP Nandakumar, MD & CEO At Manappuram Finance.


img

Exclusive - Not Right To Impose LTCG Tax: Jim Rogers

February 8: Hear Out Jim Rogers Of Roger Holdings Who Says That It’s Not Right For Any Country To Impose LTCG When It Needs Investments.


img

Will The RBI Hike Rates?

February 06: On Our Special Coverage Of The Financial Markets Today We Focus On The Credit Policy.


img

PNB Q3: PAT At Rs 230 Cr, Up 11%

February 6: Punjab National Bank On Tuesday Reported 11.10 Per Cent Increase In Net Profit For The Third Quarter Ended December 31, 2017 At Rs 230.11 Crore. To Decode The Numbers In Detail, We Caught Up With Mayuresh Joshi, Fund Manager At Angel Broking And Hemendra Hazari, Banking Expert.


img

Bond Yield At 7.54%, Rises By 6 BPS

February 2: Bond Yields have been Spiking. We Caught Up With Vetri Subramaniam, Group President And Head Of Equity at UTI Mutual Fund And Hemant Rustogi, CEO At Wiseinvest Advisors To Discuss This In Detail.


img

Bond Yields Spike Hits Markets

February 2: Bond Yields have been Spiking. We Caught Up Arvind Narayan Of DBS Bank To Discuss This In Detail.


img

Exclusive - SBI Hikes Bulk Deposit Rates

January 30: State Bank of India Has Raised Interest Rates On Bulk Deposits By 50-140 Basis Points Effective Monday. We Caught Up With PK Gupta Of SBI And Arvind Narayan Of DBS Bank To Discuss This In Detail.


img

DRL Q3: PAT At Rs.303 Crore

January 25: DRL’s Consolidated Net Profit Declined Sharply By 38.4 Per Cent To Rs.303 Crore From Rs.492 Crore in The Similar Period Of Last Year. Net Sales Declined Slightly By One Per Cent To Rs.3,616 Crore From Rs.3,653 Crore. We Caught Up With Cyndrella Carvalho, Sr. Research Analyst - Pharma at Dolat Capital To Decode The Quarter In Detail.